163 related articles for article (PubMed ID: 27854086)
1. A Review of Differences in Clinical Characteristics between Tardive Syndrome Induced or Improved by Aripiprazole Treatment.
Chen YW; Tseng PT
Acta Neurol Taiwan; 2016 Sep; 25(3):88-94. PubMed ID: 27854086
[TBL] [Abstract][Full Text] [Related]
2. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 3: Clinical Trial Data.
Preskorn SH; Macaluso M
J Psychiatr Pract; 2016 Mar; 22(2):117-23. PubMed ID: 27138080
[TBL] [Abstract][Full Text] [Related]
3. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 4: Case Report Data.
Macaluso M; Flynn A; Preskorn S
J Psychiatr Pract; 2016 May; 22(3):203-20. PubMed ID: 27123800
[TBL] [Abstract][Full Text] [Related]
4. Remission of irreversible aripiprazole-induced tardive dystonia with clozapine: a case report.
Joe S; Park J; Lim J; Park C; Ahn J
BMC Psychiatry; 2015 Oct; 15():253. PubMed ID: 26482558
[TBL] [Abstract][Full Text] [Related]
5. Movement Disorders Induced by the "Atypical" Antipsychotic Aripiprazole.
Selfani K; Soland VL; Chouinard S; Huot P
Neurologist; 2017 Jan; 22(1):24-28. PubMed ID: 28009769
[TBL] [Abstract][Full Text] [Related]
6. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder, Part 2: Preclinical and Early Phase Human Proof of Concept Studies.
Macaluso M; Flynn A; Preskorn S
J Psychiatr Pract; 2016 Jan; 22(1):42-9. PubMed ID: 26813487
[TBL] [Abstract][Full Text] [Related]
7. Improvement of tardive dyskinesia and dystonia associated with aripiprazole following a switch to quetiapine: case report and review of the literature.
Ono S; Suzuki Y; Shindo M; Endo T; Fukui N; Sugai T; Someya T
J Clin Pharm Ther; 2012 Jun; 37(3):370-2. PubMed ID: 22023382
[TBL] [Abstract][Full Text] [Related]
8. Aripiprazole-induced tardive dyskinesia in patients with schizophrenia: A case report of twins.
She S; Kuang Q; Zheng Y
Schizophr Res; 2018 Jul; 197():564-565. PubMed ID: 29128325
[No Abstract] [Full Text] [Related]
9. Management of aripiprazole-induced tardive Pisa syndrome: a case report and literature review.
De Risio L; Pettorruso M; Di Nicola M; Martinotti G; Janiri L; Fasano A
Int Clin Psychopharmacol; 2016 Jan; 31(1):57-60. PubMed ID: 26426442
[TBL] [Abstract][Full Text] [Related]
10. Tardive Dyskinesia and Covert Dyskinesia with Aripiprazole: A Case Series.
Patra S
Curr Drug Saf; 2016; 11(1):102-3. PubMed ID: 26391425
[TBL] [Abstract][Full Text] [Related]
11. Determining Whether a Definitive Causal Relationship Exists Between Aripiprazole and Tardive Dyskinesia and/or Dystonia in Patients With Major Depressive Disorder: Part 1.
Preskorn S; Flynn A; Macaluso M
J Psychiatr Pract; 2015 Sep; 21(5):359-69. PubMed ID: 26348804
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of low-Dose Aripiprazole to Treat Clozapine-Associated Tardive Dystonia in a Patient with Schizophrenia].
Huh L; Lee BJ
Turk Psikiyatri Derg; 2017; 28(3):208-211. PubMed ID: 28936820
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole in schizophrenia and schizoaffective disorder: A review.
Stip E; Tourjman V
Clin Ther; 2010; 32 Suppl 1():S3-20. PubMed ID: 20152550
[TBL] [Abstract][Full Text] [Related]
14. Aripiprazole Combined with Lamotrigine in the Treatment of a Treatment-Resistant Schizophrenic Patient with Tardive Dyskinesia and Supersensitivity Psychosis.
Peretti CS; Chouinard G
Psychother Psychosom; 2019; 88(5):313-314. PubMed ID: 31291629
[No Abstract] [Full Text] [Related]
15. Neurological, Metabolic, and Psychiatric Adverse Events in Children and Adolescents Treated With Aripiprazole.
Jakobsen KD; Bruhn CH; Pagsberg AK; Fink-Jensen A; Nielsen J
J Clin Psychopharmacol; 2016 Oct; 36(5):496-9. PubMed ID: 27504593
[TBL] [Abstract][Full Text] [Related]
16. [Antipsychotic-induced tardive syndromes].
Fleischhacker WW; Hofer A; Jagsch C; Pirker W; Psota G; Rittmannsberger H; Seppi K
Neuropsychiatr; 2016 Sep; 30(3):123-130. PubMed ID: 27580887
[TBL] [Abstract][Full Text] [Related]
17. Antipsychotic-induced Tardive dyskinesia: from biological basis to clinical management.
Salem H; Pigott T; Zhang XY; Zeni CP; Teixeira AL
Expert Rev Neurother; 2017 Sep; 17(9):883-894. PubMed ID: 28750568
[TBL] [Abstract][Full Text] [Related]
18. Use of aripiprazole in tardive dyskinesia: an open label study of six cases.
Rajarethinam R; Dziuba J; Manji S; Pizzuti A; Lachover L; Keshavan M
World J Biol Psychiatry; 2009; 10(4 Pt 2):416-9. PubMed ID: 19492247
[TBL] [Abstract][Full Text] [Related]
19. A review of 32 cases of tardive dystonia.
Wojcik JD; Falk WE; Fink JS; Cole JO; Gelenberg AJ
Am J Psychiatry; 1991 Aug; 148(8):1055-9. PubMed ID: 1677236
[TBL] [Abstract][Full Text] [Related]
20. High Incidence and Prevalence of Drug-Related Movement Disorders in Young Patients With Psychotic Disorders.
Mentzel TQ; Lieverse R; Bloemen O; Viechtbauer W; van Harten PN;
J Clin Psychopharmacol; 2017 Apr; 37(2):231-238. PubMed ID: 28141621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
